Parental history of Type 2 diabetes in patients with nonaffective psychosis

Schizophrenia Research

Volumn 98, Issue 1-3, 2008, Pages 302-306

  Fernandez Egea, Emilio ^a   Miller, Brian ^b   Bernardo, Miguel ^a   Donner, Thomas ^c   Kirkpatrick, Brian ^b  

^a Institut Clínic de Neurociències ICN   (Spain)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Family history; Nonaffective psychosis; Schizophrenia; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FATHER; FEMALE; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MALE; MENTAL DISEASE; MOTHER; NON INSULIN DEPENDENT DIABETES MELLITUS; PARENT; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; STATISTICAL MODEL;

ADULT; CHILD; CHILD OF IMPAIRED PARENTS; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MATERNAL AGE; MODELS, STATISTICAL; PARENTS; PATERNAL AGE; PREVALENCE; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ENVIRONMENT;

EID: 37049024526     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.10.002     Document Type: Article

References (41)

1. Braceland F.J., Meduna L.J., and Vaichulis J.A. Delayed action of insulin in schizophrenia. Am. J. Psychiatry 102 (1945) 108-110
2. Compton M.T., Bollini A.M., McKenzie Mack L., Kryda A.D., Rutland J., Weiss P.S., Bercu Z., Esterberg M.L., and Walker E.F. Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophr. Res. 94 1-3 (2007) 64-73 (Aug)
3. Dabelea D., and Pettitt D.J. Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J. Pediatr. Endocrinol. Metab. 14 8 (2001) 1085-1091 (Sep-Oct)
4. Delisle H. Foetal programming of nutrition-related chronic diseases. Sante 12 1 (2002) 56-63 (Jan-Mar). French
5. Dixon L., Weiden P., Delahanty J., Goldberg R., Postrado L., Lucksted A., and Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr. Bull. 26 4 (2000) 903-912
6. Frayling T.M., and Hattersley A.T. The role of genetic susceptibility in the association of low birth weight with type 2 diabetes. Br. Med. Bull. 60 (2001) 89-101
7. Freeman H. Resistance to insulin in mentally disturbed soldiers. Arch. Neurol. Psychiatry 56 (1946) 74-78
8. Gough S.C., and O'donovan M.C. Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J. Psychopharmacology 19 (2005) 47-55
9. Gourion D., Goldberger C., Bourdel M.C., Bayle F.J., Millet B., Olie J.P., and Krebs M.O. Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr. Res. 63 1-2 (2003) 181-187 (Sep 1)
10. Gourion D., Goldberger C., Olie J.P., Loo H., and Krebs M.O. Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophr. Res. 67 1 (2004) 23-31 (Mar 1)
11. Hales C.N., and Barker D.J. The thrifty phenotype hypothesis. Br. Med. Bull. 60 (2001) 5-20
12. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 Pt4 (1999) 593-624 (Apr)
13. Ismail B., Cantor-Graae E., and McNeil T.F. Minor physical anomalies in schizophrenic patients and their siblings. Am. J. Psychiatry 155 12 (1998) 1695-1702 (Dec)
14. Kasanin J. The blood sugar curve in mental disease, II: the schizophrenic (dementia praecox) group. Arch. Neurol. Psychiatry (1926) 16414-16419
15. Koenig J.I., Kirkpatrick B., and Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmcology 27 2 (2002) 309-318 (Aug)
16. Kunugi H., Nanko S., and Murray R.M. Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br. J. Psychiatry 40 (2001) s25-s29 (Suppl.) (Apr)
17. Langfeldt G. The insulin tolerance test in mental disorders. Acta Psychiatr. Scand. 80 (1952) 189-200 (suppl)
18. Laurent A., Biloa-Tang M., Bougerol T., Duly D., Anchisi A.M., Bosson J.L., Pellat J., d'Amato T., and Dalery J. Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. Schizophr. Res. 46 2-3 (2000) 269-283 (Dec 15)
19. Lichtermann D., Karbe E., and Maier W. The genetic epidemiology of schizophrenia and of schizophrenia spectrum disorders. Eur. Arch. Psychiatry Clin. Neurosci. 250 6 (2000) 304-310
20. Lorenz W.F. Sugar tolerance in dementia praecox and other mental disorders. Arch. Neurol. Psychiatry 8 (1922) 184-196
21. Mata-Cases M., Fernandez-Bertolin E., Cos-Claramunt X., Garcia-Duran M., Mateu-Gelabert T., Pareja-Rossell C., and Pujol-Ribera E. Incidence of type 2 diabetes and its diagnosis process in the decade 1991-2000 in a primary health care centre. Gac. Sanit. 20 2 (2006) 124-131 (Mar-Apr) Spanish
22. Meduna L.J., Gerty F.J., and Urse V.G. Biochemical disturbances in mental disorders. Arch. Neurol. Psychiatry (1942) 4738-4752
23. Meltzer H.Y., and McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 25 2 (1999) 233-255
24. Moller D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 11 6 (2000) 212-217 (Aug)
25. Mukherjee S., Schnur D.B., and Reddy R. Family history of type 2 diabetes in schizophrenic patients. Lancet 1 (1989) 495 (letter)
26. Osmond C., and Barker D.J. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ. Health Perspect. 108 Suppl 3 (2000) 545-553 (Jun)
27. Ozanne S.E., and Hales C.N. Early progamming of glucose-insulin metabolism. Trends Endocrinol. Metab. 13 9 (2002) 368-373 (Nov)
28. Ravelli A.C., van der Meulen J.H., Michels R.P., Osmond C., Barker D.J., Hales C.N., and Bleker O.P. Glucose tolerance in adults after prenatal exposure to famine. Lancet 351 9097 (1998) 173-177 (Jan 17)
29. Regenold W.T., Thapar R.K., Marano C., Gavirneni S., and Kondapavuluru P.V. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 70 1 (2002) 19-26 (Jun)
30. Robinson G.W., and Shelton P. Incidence and Interpretation of Diabetic-Like Dextrose Tolerance Curves in Nervous and Mental Patients (1940), JAMA 1142279
31. Roseboom T.J., van der Meulen J.H., Ravelli A.C., Osmond C., Barker D.J., and Bleker O.P. Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Mol. Cell. Endocrinol. 185 1-2 (2001) 93-98 (Dec)
32. Ryan M.C., Collins P., and Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 160 2 (2003) 284-269 (Feb)
33. Saoud M., d'Amato T., Gutknecht C., Triboulet P., Bertaud J.P., Marie-Cardine M., Dalery J., and Rochet T. Neuropsychological deficit in siblings discordant for schizophrenia. Schizophr. Bull. 26 4 (2000) 893-902
34. Spelman L.M., Walsh P.I., Sharifi N., Collins P., and Thakore J.H. Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia. Diabet. Med. 24 5 (2007) 481-485 (May)
35. Sponheim S.R., McGuire K.A., and Stanwyck J.J. Neural anomalies during sustained attention in first-degree biological relatives of schizophrenia patients. Biol. Psychiatry 60 3 (2006) 242-252 (Aug 1)
36. Thermenos H.W., Seidman L.J., Breiter H., Goldstein J.M., Goodman J.M., Poldrack R., Faraone S.V., and Tsuang M.T. Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biol. Psychiatry 55 5 (2004) 490-500 (Mar 1)
37. Wahlbeck K., Forsen T., Osmond C., Barker D.J., and Eriksson J.G. Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood. Arch. Gen. Psychiatry 58 1 (2001) 48-52 (Jan)
38. Wang H., Sowell M.O., Cavazzoni P., Qing Z., and Breier A. Retrospective assessment of pre-existing diabetes progression in clinical trials of patients with serious mental illness. Schizophr. Res. 60 1 (2003) 369 (Mar)
39. Wynn J.K., Dawson M.E., Schell A.M., McGee M., Salveson D., and Green M.F. Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biol. Psychiatry 55 5 (2004) 518-523 (Mar 1)
40. Yazici A.H., Demir B., Yazici K.M., and Gogus A. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr. Res. 58 2-3 (2002) 241-246 (Dec 1)
41. Zai G., Muller D.J., Volavka J., Czobor P., Lieberman J.A., Meltzer H.Y., and Kennedy J.L. Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication. Psychopharmacology 188 2 (2006) 171-182 (Berl) (Oct)